Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Improving Risk Stratification for Cardiovascular Disease

SPECT myocardial perfusion imaging (MPI) is a well-validated noninvasive test to determine if coronary artery disease (CAD) is the cause of a patients chest pain. While SPECT will continue to play a role in this patient population, other tests are helping to fill in the gaps in identifying those at risk of cardiac events.

Proving the Value of Registries

This issue provides updates on several important applications of molecular imaging. The cover story presents novel ideas to better identify patients who are at risk for or have coronary artery disease.

On the Verge: Inside Clinical Trials that Could Change Patient Care

PET imaging is effective in staging, restaging, detecting recurrence and treatment monitoring across a wide range of cancers.

Electrophysiology Procedure Planning: Using Nuclear Modalities to Help Guide Ablations & Patient Selection

Due to the commonality of these arrhythmias and the number of procedures necessary to treat them, there is a growing need for the field of electrophysiology (EP). And to better treat patients with dangerous arrhythmias, practitioners have begun using cardiac PET and SPECT to help in patient selection and to guide EP procedures including ablations, lead placements and CRT implantations.

Preclinical to Clinical 18F-FLT PET Imaging Moving from Mice to Men

One of the most promising radiopharmaceuticals is the proliferation marker 3'-deoxy-3'-[18F] fluorothymidine (18F-FLT). 

MR Systems Garner FDA Clearance

GE Healthcare yesterday announced FDA clearance of its Optima™ MR360 1.5T and Brivo™ MR355 1.5T magnetic resonance systems. Approximately 180 such systems have been ordered by hospitals and imaging centers worldwide.

Toshiba Launches MR System Upgrade Program

Toshiba America Medical Systems, Inc. has introduced an upgrade program for its Vantage™ 1.5T MR systems. Promoted as a cost-effective alternative to purchasing a new system, the renew ™ program offers Toshiba Vantage users a number of options throughout the entire Vantage suite, including upgrade paths to a Vantage Atlas® or a Vantage Titan™.

Musculoskeletal MR System Receives FDA Clearance

GE Healthcare late last week announced FDA clearance of its new Optima™ MR430s 1.5T scanner. Intended to deliver precise imaging of the arm, including the elbow, wrist, and hand; or the leg, including the knee, ankle, and foot, the musculoskeletal MR system delivers 70mT/m of strength and 300T/m/s of slew rate. Short echo spacing and a high signal